163 related articles for article (PubMed ID: 1514885)
21. Neurophysiological evidence for muscle tone reduction by intrathecal baclofen at the brainstem level.
Kumru H; Stetkarova I; Schindler C; Vidal J; Kofler M
Clin Neurophysiol; 2011 Jun; 122(6):1229-37. PubMed ID: 20889372
[TBL] [Abstract][Full Text] [Related]
22. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries.
Korenkov AI; Niendorf WR; Darwish N; Glaeser E; Gaab MR
Neurosurg Rev; 2002 Aug; 25(4):228-30. PubMed ID: 12172730
[TBL] [Abstract][Full Text] [Related]
23. Implantable baclofen pump as an adjuvant in treatment of pressure sores.
Mess SA; Kim S; Davison S; Heckler F
Ann Plast Surg; 2003 Nov; 51(5):465-7. PubMed ID: 14595181
[TBL] [Abstract][Full Text] [Related]
24. Functional outcome of intrathecal baclofen administration for severe spasticity.
Boviatsis EJ; Kouyialis AT; Korfias S; Sakas DE
Clin Neurol Neurosurg; 2005 Jun; 107(4):289-95. PubMed ID: 15885386
[TBL] [Abstract][Full Text] [Related]
25. [Case report of intrathecal baclofen administration in a child with severe spasticity attributable to traumatic brain injury].
Matsuda R; Nishimura F; Hirabayashi H; Motoyama Y; Mishima H; Park YS; Nakase H; Sakaki T
Brain Nerve; 2009 Mar; 61(3):313-5. PubMed ID: 19301603
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial.
Bresolin N; Zucca C; Pecori A
Adv Ther; 2009 May; 26(5):563-73. PubMed ID: 19458926
[TBL] [Abstract][Full Text] [Related]
27. Quality of life of patients with telemetric pumps for intrathecal baclofen infusion: data and limitations of assessment scales.
Bramanti P; D'Aleo G; Rifici C; Alagna A; Cannata A; Sessa E; Di Bella P; Marra G
Funct Neurol; 2004; 19(4):227-31. PubMed ID: 15776790
[TBL] [Abstract][Full Text] [Related]
28. Intrathecal baclofen in severe spasticity.
McLean BN
Br J Hosp Med; 1993 Feb 17-Mar 2; 49(4):262-7. PubMed ID: 8443626
[TBL] [Abstract][Full Text] [Related]
29. Continuous intrathecal baclofen in spinal cord spasticity. A prospective study.
Meythaler JM; Steers WD; Tuel SM; Cross LL; Haworth CS
Am J Phys Med Rehabil; 1992 Dec; 71(6):321-7. PubMed ID: 1466869
[TBL] [Abstract][Full Text] [Related]
30. Continuous intrathecal baclofen administration by a fully implantable electronic pump for severe spasticity treatment: our experience.
Guglielmino A; Sorbello M; Fazzio S; Zingale SF; Bucolo GE; Pittalà G; Castiglione A; Patti F; Mangiameli S
Minerva Anestesiol; 2006 Oct; 72(10):807-20. PubMed ID: 17006418
[TBL] [Abstract][Full Text] [Related]
31. Intrathecal baclofen infusion for ambulant children with cerebral palsy.
Brochard S; Remy-Neris O; Filipetti P; Bussel B
Pediatr Neurol; 2009 Apr; 40(4):265-70. PubMed ID: 19302938
[TBL] [Abstract][Full Text] [Related]
32. Performance and complications associated with the synchromed 10-ml infusion pump for intrathecal baclofen administration in children.
Albright AL; Awaad Y; Muhonen M; Boydston WR; Gilmartin R; Krach LE; Turner M; Zidek KA; Wright E; Swift D; Bloom K
J Neurosurg; 2004 Aug; 101(1 Suppl):64-8. PubMed ID: 16206974
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of posterior spinal fusion and instrumentation in patients with continuous intrathecal baclofen infusion pumps.
Caird MS; Palanca AA; Garton H; Hensinger RN; Ayyangar RN; Drongowski A; Farley FA
Spine (Phila Pa 1976); 2008 Feb; 33(4):E94-9. PubMed ID: 18277862
[TBL] [Abstract][Full Text] [Related]
34. Dosage of intrathecal baclofen maintenance therapy in the spastic syndromes.
Fares Y; Khazim RM; del Barrio ER; Burzaco JA
J Med Liban; 2004; 52(1):13-8. PubMed ID: 15881696
[TBL] [Abstract][Full Text] [Related]
35. Functional improvement in patients with severe spinal spasticity treated with chronic intrathecal baclofen infusion.
Dario A; Scamoni C; Bono G; Ghezzi A; Zaffaroni M
Funct Neurol; 2001; 16(4):311-5. PubMed ID: 11853321
[TBL] [Abstract][Full Text] [Related]
36. Dose-response relationship between the H-reflex and continuous intrathecal baclofen administration for management of spasticity.
Stokic DS; Yablon SA; Hayes A; Vesovic-Potic V; Olivier J
Clin Neurophysiol; 2006 Jun; 117(6):1283-9. PubMed ID: 16621691
[TBL] [Abstract][Full Text] [Related]
37. GMFM 1 year after continuous intrathecal baclofen infusion.
Krach LE; Kriel RL; Gilmartin RC; Swift DM; Storrs BB; Abbott R; Ward JD; Bloom KK; Brooks WH; Madsen JR; McLaughlin JF; Nadell JM
Pediatr Rehabil; 2005; 8(3):207-13. PubMed ID: 16087555
[TBL] [Abstract][Full Text] [Related]
38. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity.
Guillaume D; Van Havenbergh A; Vloeberghs M; Vidal J; Roeste G
Arch Phys Med Rehabil; 2005 Nov; 86(11):2165-71. PubMed ID: 16271565
[TBL] [Abstract][Full Text] [Related]
39. Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study.
Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Sleypen FA; Vles JS;
Dev Med Child Neurol; 2007 Sep; 49(9):654-9. PubMed ID: 17718820
[TBL] [Abstract][Full Text] [Related]
40. A neurophysiological method for the evaluation of motor performance in spastic walking patients.
Dones I; Servello D; Molteni F; Mariani G; Broggi G
Acta Neurochir Suppl; 1995; 64():26-9. PubMed ID: 8748578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
